Mast cells activation and high blood tryptase levels due to paclitaxel administration. Is Cremophor EL the culprit?: A case report

RATIONALE: Although the cancer incidence continues to rise, cancer mortality has declined over the past decade, in large part due to more efficacious chemotherapeutic regimens thus, the ability to use first-line chemotherapeutic agents in the treatment of patients with cancer is crucial. Antineoplas...

Descripción completa

Detalles Bibliográficos
Autores principales: D’Errico, Stefano, Baldari, Benedetta, Arcangeli, Mauro, Santurro, Alessandro, Frati, Paola, Fineschi, Vittorio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
4200
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7581127/
https://www.ncbi.nlm.nih.gov/pubmed/33120804
http://dx.doi.org/10.1097/MD.0000000000022814

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7581127/
https://www.ncbi.nlm.nih.gov/pubmed/33120804
http://dx.doi.org/10.1097/MD.0000000000022814

Ejemplares similares